Skip to main content
EJNMMI Research
Figure 4 | EJNMMI Research

Figure 4

From: The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®

Figure 4

Biodistribution of 177Lu-DAB4 in LL2 tumour-bearing mice. LL2 tumour-bearing mice were given RIT (177Lu-DAB4 or 177Lu-Sal5) alone or after chemotherapy (chemo), and (A) Tissue accumulation of radioactivity was assayed. * p < 0.05 (two-way ANOVA), n = 4. (B) The same tumours were sectioned, and imaged using a MicroImager.

Back to article page